Patient-Specific Organoid for Treating Cancer
April 2, 2019 | Terry Sharrer
Cancer of the appendix is rare—about 1:100,000 people; consequently, knowledge about how to treat these cases is rare. To address this, researchers at The Wake Forest Institute of Regenerative Medicine are growing appendix-tumor organoids and are using the tumor’s sequencing data to target the disease’s growth features. Most surprising about this is the high percentage organoids that have been grown. MORE
Image Credit: Wikimedia.commons